Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra-articular administration to exercised Thoroughbred horses.

The research study investigates the behavior of the drug isoflupredone acetate inside the bodies of Thoroughbred racing horses after administration. It highlights how long the drug’s presence can be detected in various parts of the horse’s body, such as blood, urine, and synovial fluid.

Objective of the Research

• The main purpose of this study was to detail the pharmacokinetics of isoflupredone acetate in the plasma of horses, as well as gauge the change in concentration of the drug over time in the urine and synovial fluid of horses, following intra-articular administration.

Methodology

• The experiment involved twelve adult Thoroughbred horses fit for racing. These animals were subjected to a single dose (8 mg) of isoflupredone acetate directly into their right antebrachiocarpal joint.
• Blood, urine, and synovial fluid samples were collected from these horses before the drug administration and then periodically over the next 28 days.
• These collected samples were then analyzed using a technique known as liquid chromatography-mass spectrometry.
• The plasma data from all horses were further analyzed using a population pharmacokinetic compartmental model, which helps understand how the drug behaves within an organism.

Results and Observations

• The highest detected plasma isoflupredone concentrations amounted to 1.76 ± 0.526 ng/mL at 4.0 ± 1.31 hours and 1.63 ± 0.243 ng/mL at 4.75 ± 0.5 hours for horses from which synovial fluid was collected, and those from which it was not collected, respectively.
• The half-life of isoflupredone in the horse’s plasma was observed to be about 24.2 hours.
• The drug was no longer present in quantities that could be detected in all horses after 48 hours and 7 days in the plasma and urine, respectively.
• In the right antebrachiocarpal and middle carpal joints, however, isoflupredone could be detected for 8.38 ± 5.21 and 2.38 ± 0.52 days, respectively.

Research Implications

• The findings of this research provide valuable information that could be utilized to make informed assessments about the regulation of intra-articular isoflupredone usage in horses, especially those that participate in racing events. It may assist in better understanding the impact of the drug on a horse’s performance and also help in framing clear policies around drug use in the racing industry.